MedTrace Logo

Text Reminders to Immunize in a Managed Care Organization

NCT01806714 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3812

Last updated 2017-06-26

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to evaluate the effectiveness of a managed care-based HPV vaccination reminder/recall system using a randomized controlled trial (RCT) across diverse practices and patient populations. The trial will measure the effectiveness of text messaging reminder/recall on (a) improving initiation and (b) completion rate of the HPV vaccine series; (c) decreasing the time between vaccine doses; and (d) improving rates of preventive visits for adolescents

The hypotheses are that text-messaged reminders to parents of adolescents will result in improved rates of HPV vaccine series initiation, HPV vaccine series completion, will decrease the intervals between vaccine doses and will improve rates of preventive care among adolescents. Parents receiving specific text-messaged reminders about services (i.e. HPV vaccination, well child care visits) for which their adolescent is due will be compared to a control group of parents receiving general health tips through text messages.

Conditions

Interventions

OTHER

Text-based reminder for recommended HPV vaccine or WCC

Patients due for a well visit or HPV vaccine received a text reminder

OTHER

Non-specific text-based reminder (general health tip)

Parents of adolescents receive preventive health tips via text messages (not specific to services for which child is due)

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Cynthia M Rand, MD, MPH · University of Rochester

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01806714 on ClinicalTrials.gov